Boston Scientific (NYSE:BSX) announced today that it agreed to acquire infusion pump maker Intera Oncology for an undisclosed amount. Intera Oncology develops the Intera 3000 hepatic artery infusion pump and floxuridine, a chemotherapy drug. Both hold FDA approval. The pump administers hepatic artery infusion (HAI) therapy to treat tumors in the … [Read more...] about Boston Scientific to acquire hepatic artery infusion pump maker Intera Oncology
Business
Medtronic acquires articulating instrument maker Fortimedix Surgical
Fortimedix Surgical announced today that it has been acquired by medtech giant Medtronic (NYSE:MDT). "We are pleased to share that Fortimedix Surgical was acquired by Medtronic," the company wrote on LinkedIn. "A unique opportunity to leverage our articulating instrument technology for application across patient therapies. We look forward to … [Read more...] about Medtronic acquires articulating instrument maker Fortimedix Surgical
EndoTheia completes first-in-human study of steerable kidney stone basket
EndoTheia announced today that it completed the first-in-human clinical trial for its FlexStone basket, a steerable kidney stone treatment. Nashville, Tennessee-based EndoTheia said its FlexStone basket represents the first-ever independently steerable kidney stone basket. It enables precision and control in kidney stone removal by letting … [Read more...] about EndoTheia completes first-in-human study of steerable kidney stone basket
Lubrizol partners with Polyhose on medical tubing plant in India
Lubrizol (Wickliffe, Ohio) announced today that it will work with Polyhose (Wilmington, North Carolina) to create a medical tubing plant in Chennai, India's home state of Tamil Nadu. The new site enables Lubrizol to boost its local medical tubing volume five-fold. The tubing will go toward neurovascular and cardiovascular medical applications, … [Read more...] about Lubrizol partners with Polyhose on medical tubing plant in India
Otsuka partners with ICU Medical to enter U.S. IV products market
Otsuka Holdings will pay ICU Medical (Nasdaq: ICUI) an upfront payment of $200 million as part of a joint venture to enter the U.S. IV products market, which has been facing hurricane-related shortages this fall. The partnership — which involves ICU Medical providing commercial services for Otsuka’s Otsuka Pharmaceutical Factory (OPF) … [Read more...] about Otsuka partners with ICU Medical to enter U.S. IV products market
Vascular stent graft maker Solaris Endovascular launches to address vascular health challenges
Solaris Endovascular today announced its formation to develop solutions for dialysis access and treating peripheral artery disease (PAD). The New Orleans-based company develops technologies to treat and extend the patency of dialysis access fistulae, grafts, and peripheral arteries. It aims to enable patients to lead healthier lives with fewer … [Read more...] about Vascular stent graft maker Solaris Endovascular launches to address vascular health challenges
Boston Scientific to acquire Cortex and its cardiac mapping tech
Boston Scientific (NYSE: BSX) announced today that it will purchase Ajax Health's Cortex and its FDA-cleared OptiMap system to guide physicians performing ablation procedures to treat AFib Financial terms of the deal were not disclosed. Boston Scientific expects to complete the transaction in the first half of 2025, subject to customary closing … [Read more...] about Boston Scientific to acquire Cortex and its cardiac mapping tech
Merit Medical completes acquisition of Cook Medical’s lead management portfolio
Merit Medical Systems (Nasdaq:MMSI) announced today that it completed its acquisition of Cook Medical’s lead management portfolio. South Jordan, Utah-based Merit announced its agreement to buy the portfolio for $210 million in September. Merit funded the acquisition through a combination of cash on hand and borrowings under a long-term credit … [Read more...] about Merit Medical completes acquisition of Cook Medical’s lead management portfolio
Nerve ablation tech developer Autonomix to effect a reverse stock split
Autonomix (Nasdaq:AMIX) announced today that it filed to effect a 1-for-20 reverse stock split of its common stock. The Woodlands, Texas-based Autonomix plans for the split to take effect at 11:59 p.m. ET on Oct. 24, 2024. It plans for its common stock to open trading on the Nasdaq market on Oct. 25, 2024, on a post-split basis, under the … [Read more...] about Nerve ablation tech developer Autonomix to effect a reverse stock split
Gradient adds former Edwards exec to board as FDA approves trial expansion
Gradient Denervation Technologies announced today that it appointed medical device entrepreneur and executive Stanton Rowe to its board. Paris-based Gradient also said the FDA approved an expansion of its early feasibility study of its hypertension treatment. The company develops a minimally invasive, ultrasound-based catheter device for … [Read more...] about Gradient adds former Edwards exec to board as FDA approves trial expansion
